Replies to post #203 on Vanda Pharmaceuticals, Inc. (VNDA)

[mlkrborn]

Good solid pharma with profit!

[surf1944]

7:01AM Vanda Pharma receives Orphan Drug designation in Europe for tasimelteon (VNDA) 7.25 : Co announced that the European Commission has granted Orphan Drug designation for tasimelteon, an oral dual melatonin receptor agonist in Phase III clinical trails for Non-24-Hour Sleep/Wake Disorder in blind individuals with no light perception.